We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Optimized nanoparticle-mediated delivery of CRISPR-Cas9 system for B cell intervention.
- Authors
Li, Min; Fan, Ya-Nan; Chen, Zhi-Yao; Luo, Ying-Li; Wang, Yu-Cai; Lian, Zhe-Xiong; Xu, Cong-Fei; Wang, Jun
- Abstract
B cells exert multiple effector functions, and dysfunctions of B cells often lead to initiation and progression of diseases, including autoimmune and inflammatory diseases. Therefore, B cell intervention may be an effective strategy to treat diseases involving B cells. The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene editing system has been widely used for DNA deletion, insertion, and replacement. Nanocarriers have been developed as relatively mature systems and may be applied to deliver the CRISPR-Cas9 system to B cells in vivo. In this study, we created a library of nanoparticles (NPs) with different polyethylene glycol densities and zeta potentials and screened an optimal NP for in vivo B cell targeting. The selected NP could deliver the CRISPR-Cas9 system to B cells and induce Cas9 expression inside the cell environment. Injection of the NP encapsulated with Cas9/gB220 (NPCas9/gB220) into mice could disrupt B220 expression in B cells, suggestive of its applications to intervene the expression of the target molecule in B cells. Moreover, the treatment with NPCas9/gBAFFR could decrease the number of B cells and exert therapeutic effect in rheumatoid arthritis, as B-cell activating factor receptor (BAFFR) is vital for the survival and functions of B cells. In conclusion, we developed a carrier for the delivery of the CRISPR-Cas9 gene editing system for B cell intervention that could be used for the treatment of diseases related to B cell dysfunctions.
- Publication
Nano Research, 2018, Vol 11, Issue 12, p6270
- ISSN
1998-0124
- Publication type
Article
- DOI
10.1007/s12274-018-2150-5